Based on this, it can be concluded that a more diverse T-cell repertoire, stimulated by a diverse intestinal microbiota, might inhibit tumor growth besides tumor suppressive effects of anti-PD-1 therapy. This evidence concerns the gene PDCD1 and neoplasm.